Reviewing Odyssey Health (OTCMKTS:ODYY) & Enovis (NYSE:ENOV)

Enovis (NYSE:ENOV) and Odyssey Health (OTCMKTS:ODYY) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation and institutional ownership.

Profitability

This table compares Enovis and Odyssey Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Enovis	-47.96%	12.03%	4.91%
Odyssey Health	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent recommendations for Enovis and Odyssey Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1	1	8	0	2.70
Odyssey Health	0	0	0	0	0.00

Enovis currently has a consensus price target of $42.00, suggesting a potential upside of 68.16%. Given Enovis’ stronger consensus rating and higher probable upside, equities research analysts plainly believe Enovis is more favorable than Odyssey Health.

Insider & Institutional Ownership

98.5% of Enovis shares are held by institutional investors. 2.9% of Enovis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Enovis and Odyssey Health”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.25 billion	0.64	-$1.18 billion	($19.26)	-1.30
Odyssey Health	N/A	N/A	N/A	N/A	N/A

Odyssey Health has lower revenue, but higher earnings than Enovis.

Summary

Enovis beats Odyssey Health on 8 of the 9 factors compared between the two stocks.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

About Odyssey Health

Odyssey Health, Inc., a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and ONP -001 and ONP -002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.